Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory R Pond

Showing results (11-20 of 255) with videos related to

Pageof 26
Sort By:
BJU International|September 9, 2014
Nomogram to predict the benefit from salvage systemic therapy for advanced urothelial carcinomaGuru Sonpavde, Gregory R Pond, Ronan Fougeray, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2006
Long-term survival after blood and marrow transplantation: comparison with an age- and gender-matched normative populationGregory R Pond, Jeffrey H Lipton, Hans A Messner
Journal of the American Academy of Dermatology|August 28, 2002
Prognostic factors for life expectancy in nonagenarians with nonmelanoma skin cancer: implications for selecting surgical candidatesAlix J Charles, Clark C Otley, Gregory R Pond
Journal of Neurosurgery. Pediatrics|January 14, 2023
Rurality index score and pediatric neuro-oncological outcome in OntarioMichelle Masayo Kameda-Smith, Gregory R Pond, Hsien Seow
Clinical Journal of Oncology Nursing|March 31, 2012
The impact of chemotherapy-induced cognitive impairment on the psychosocial adjustment of patients with nonmetastatic colorectal cancerJacqueline Galica, Dale Rajacich, Debbie Kane, et al.
Current Oncology (Toronto, Ont.)|August 25, 2023
Trainee Evaluations of Preparedness for Clinical Trials in Medical Oncology-A National QuestionnaireMichela Febbraro, Ghazaleh Kazemi, Rosalyn Juergens, et al.
Clinical Biochemistry|February 4, 2012
Statistical and analytical approaches for assessing biomarkers: new approaches, new technologies, with the same-old rigor for evaluationMatthew P A Henderson, Gregory R Pond, Peter A Kavsak
Current Oncology (Toronto, Ont.)|December 22, 2022
Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-AnalysisArani Sathiyapalan, Michela Febbraro, Gregory R Pond, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 20, 2025
The Impact of Chronic Obstructive Pulmonary Disease on Immune Checkpoint Inhibitor Effectiveness in Non-small Cell Lung Cancer: A Population Health StudySze Wah Samuel Chan, Gregory R Pond, John R Goffin
Middle East African Journal of Ophthalmology|August 21, 2018
Outcome Analysis of Visual Acuity and Side Effect after Ruthenium-106 Plaque Brachytherapy for Medium-sized Choroidal MelanomaTahra AlMahmoud, Sean Quinlan-Davidson, Gregory R Pond, et al.
Pageof 26

Showing results (11-20 of 255) with videos related to

Sort By:
Pageof 26
BJU International|September 9, 2014
Nomogram to predict the benefit from salvage systemic therapy for advanced urothelial carcinomaGuru Sonpavde, Gregory R Pond, Ronan Fougeray, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2006
Long-term survival after blood and marrow transplantation: comparison with an age- and gender-matched normative populationGregory R Pond, Jeffrey H Lipton, Hans A Messner
Journal of the American Academy of Dermatology|August 28, 2002
Prognostic factors for life expectancy in nonagenarians with nonmelanoma skin cancer: implications for selecting surgical candidatesAlix J Charles, Clark C Otley, Gregory R Pond
Journal of Neurosurgery. Pediatrics|January 14, 2023
Rurality index score and pediatric neuro-oncological outcome in OntarioMichelle Masayo Kameda-Smith, Gregory R Pond, Hsien Seow
Clinical Journal of Oncology Nursing|March 31, 2012
The impact of chemotherapy-induced cognitive impairment on the psychosocial adjustment of patients with nonmetastatic colorectal cancerJacqueline Galica, Dale Rajacich, Debbie Kane, et al.
Current Oncology (Toronto, Ont.)|August 25, 2023
Trainee Evaluations of Preparedness for Clinical Trials in Medical Oncology-A National QuestionnaireMichela Febbraro, Ghazaleh Kazemi, Rosalyn Juergens, et al.
Clinical Biochemistry|February 4, 2012
Statistical and analytical approaches for assessing biomarkers: new approaches, new technologies, with the same-old rigor for evaluationMatthew P A Henderson, Gregory R Pond, Peter A Kavsak
Current Oncology (Toronto, Ont.)|December 22, 2022
Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-AnalysisArani Sathiyapalan, Michela Febbraro, Gregory R Pond, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 20, 2025
The Impact of Chronic Obstructive Pulmonary Disease on Immune Checkpoint Inhibitor Effectiveness in Non-small Cell Lung Cancer: A Population Health StudySze Wah Samuel Chan, Gregory R Pond, John R Goffin
Middle East African Journal of Ophthalmology|August 21, 2018
Outcome Analysis of Visual Acuity and Side Effect after Ruthenium-106 Plaque Brachytherapy for Medium-sized Choroidal MelanomaTahra AlMahmoud, Sean Quinlan-Davidson, Gregory R Pond, et al.
Pageof 26